Trial Site Detail

 

Drug:
Dasatinib (BMS-354825)
Trial:
Phase I (PH I) Mad Refractory Solid Tumor Study
Conditions: Neoplasms
Trial Status:
Completed

 

Dana Farber Cancer Institute

450 Brookline Ave     
Boston , MA 02215-5450
USA

 

Principal Investigator:
George Demetri, MD, PhD
Contact:
Melissa Hohos 617 632-2201 mhohos@partners.org
Activation Status of this Site:
Closed
Notes about this Site:
Dana Farber Cancer Institute Website:
http://www.dana-farber.org/Research/Clinical-Trials.aspx

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.